VIVALDI COELHO ROGERIO (President and CEO) reported 1 transaction at SIGILON THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/10/2020ACC: 0001104659-20-134299
DirectorOfficer· President and CEO
Since Dec 2020
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
22.22K acquired · 22.22K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+22.22K
Price / share
—
Trade value
—
% of position
New position
12/8/2020
0.00→22.22K
Total
Net shares
+22.22K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/8/2020 | C · Conversion | +22.22K | — | — | New position | 0.00 | 22.22K |
| Total | +22.22K | $0.00 | ||||||
Derivative Transactions1
Series B Convertible Preferred Stock
Direct
Converts to
Common Stock
22.22K shares
Shares
−22.22K
Strike price
Held after
0.00
Exercisable
—
12/8/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred Stock Direct | Common Stock22.22K shares | 12/8/2020 | C · Conversion | −22.22K | — | 0.00 |